NUTX

Nutex Health's stock experienced significant movement in the past six months, driven by strong Q2 2026 earnings that substantially beat analyst estimates, leading to positive analyst upgrades and increased price targets. The company demonstrated enhanced profitability and operational efficiency, and authorized a $25.0 million stock repurchase program. However, a cybersecurity event in August 2026, where allegedly obtained data was published, weighed on investor sentiment. The company also announced a dual listing on Nasdaq Texas to expand visibility and saw historically high short interest. Overall, the stock achieved significant gains, increasing by approximately 114% and reaching a new 52-week high.